Comparing the Effectiveness of Lung Expansion Therapy in Adult Human Subjects
A Randomized Controlled Trial Comparing the Effectiveness of Lung Expansion Therapy Following Upper Abdominal Surgery in Adult Human Subjects
1 other identifier
interventional
112
1 country
1
Brief Summary
The purpose of this study is to better understand how air is spread throughout study participants' lungs after abdominal surgery by comparing two lung inflation treatments:
- 1.Incentive Spirometry (I.S.) lung expansion therapy
- 2.EzPAP® lung expansion therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 28, 2016
CompletedFirst Posted
Study publicly available on registry
September 8, 2016
CompletedStudy Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 12, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 12, 2018
CompletedNovember 19, 2018
November 1, 2018
1.9 years
August 28, 2016
November 16, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ventral and Dorsal end-expiratory lung impedance redistribution of ventilation
EIT will be used to measure ventral and dorsal change in end-expiratory lung impedance before and after lung expansion therapy. Ventral and Dorsal lung impedance measurement is displayed on the EIT device as a percent (zero to 100). Investigators will record values into an electronic code book before and after lung expansion therapy. The difference between measured values will be used to quantify ventral and dorsal redistribution of ventilation. * Statistical analysis * An independent samples t-test or Mann-Whitney U test will be applied to determine if a statistically significant mean difference exists between groups. * Data will be reported as mean (SD) and 95% CI or median (IQR) depending upon normality of distribution. * Effect size = r (small effect \</= 0.1; medium effect = 0.3; Large effect \>/= 0.5 * Alpha set at ≤ 0.05 (two-tailed)
Two years
Secondary Outcomes (1)
Incidences of post-operative pulmonary complications
Two years
Study Arms (2)
Incentive Spirometry Group
OTHER* Participant will be asked to take 10 deep breaths through the mouthpiece of an incentive spirometer, followed by a 60 second pause. * This cycle will be repeated two more times. * A Respiratory Therapist will coach participants three times per day. * Each duration of Incentive Spirometry will last about 15 minutes.
EzPAP® Positive Airway Pressure Group
ACTIVE COMPARATOR* Participant will be coached by a Respiratory Therapist to breathe through the mouthpiece of an EzPAP® device for 10 breaths, followed by a 60 second pause. * This cycle will be repeated two more times. * The Respiratory Therapist will coach participants three times per day. * Each duration of EzPAP® therapy will last about 15 minutes.
Interventions
A respiratory therapist will provide instruction on Incentive Spirometry (I.S.) procedure performance before supervised therapy and monitoring begins. * Study participants will be asked to take 10 deep breaths through the I.S.'s mouthpiece, followed by a 60 second pause. * The 10-breath cycle will be repeated 3 times per therapy session. * Each I.S. therapy session will last about 15 minutes, 3 times per day. * Lung monitoring and deep breathing measurements will occur during a scheduled I.S. sessions on day 1, 3, and 5 after surgery.
A respiratory therapist will provide instruction on EzPAP® procedure performance before supervised therapy and monitoring begins. * Study participants will be asked to breathe normally through the EzPAP® device's mouthpiece for 10 breaths, followed by a 60 second pause. * The 10-breath cycle will be repeated 3 times. * Each EzPAP® therapy sessions will last about 15 minutes, 3 times per day. * Lung monitoring will occur during a scheduled EzPAP® sessions on day 1, 3, and 5 after surgery.
Eligibility Criteria
You may qualify if:
- Human subjects 18 - 79 years of age
- Post-operative upper abdominal surgery
- Examples:
- Laparotomy
- Biliodigestive anastomosis
- Cholecystectomy
- Enterectomy
- Esophagectomy
- Gastrectomy
- Hepatectomy
- Pancreatectomy
- Unassisted spontaneous breathing
- Attending surgeon's approval
- Anticipated post-operative hospital length of stay greater than 3 days
- Documentation of written informed consent
- +1 more criteria
You may not qualify if:
- Less than 18 or greater than 79 years of age
- Anticipated post-operative hospital length of stay less than 3 days
- Body mass index \> 50
- Excessive chest hair
- Inability to obtain written informed consent
- Inability to follow verbal instructions
- Pregnancy-self reported
- uncontrolled body movements
- Insertion of an artificial airway
- Hemodynamic instability
- Loss of skin integrity at site where EIT electrodes and belt are projected to come into contact (i.e., chest burns, open wounds/lesions, etc…).
- Chest tube or dressings that prohibit placement of EIT electrodes and belt
- Active implants (i.e., cardiac pacemaker, implantable cardioverter-defibrillator \[ICD\]), diaphragm pacer, or when device compatibility is in doubt.)
- Invasive or non-invasive mechanical ventilation support
- Unstable spinal lesions or fractures
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Virginialead
- Draeger Medical, Inccollaborator
Study Sites (1)
University of Virginia Medical Center
Charlottesville, Virginia, 22903, United States
Related Publications (12)
do Nascimento Junior P, Modolo NS, Andrade S, Guimaraes MM, Braz LG, El Dib R. Incentive spirometry for prevention of postoperative pulmonary complications in upper abdominal surgery. Cochrane Database Syst Rev. 2014 Feb 8;2014(2):CD006058. doi: 10.1002/14651858.CD006058.pub3.
PMID: 24510642BACKGROUNDFagevik Olsen M, Wennberg E, Johnsson E, Josefson K, Lonroth H, Lundell L. Randomized clinical study of the prevention of pulmonary complications after thoracoabdominal resection by two different breathing techniques. Br J Surg. 2002 Oct;89(10):1228-34. doi: 10.1046/j.1365-2168.2002.02207.x.
PMID: 12296888BACKGROUNDGarrard CS, Shah M. The effects of expiratory positive airway pressure on functional residual capacity in normal subjects. Crit Care Med. 1978 Sep-Oct;6(5):320-2. doi: 10.1097/00003246-197809000-00004.
PMID: 363357BACKGROUNDHinz J, Neumann P, Dudykevych T, Andersson LG, Wrigge H, Burchardi H, Hedenstierna G. Regional ventilation by electrical impedance tomography: a comparison with ventilation scintigraphy in pigs. Chest. 2003 Jul;124(1):314-22. doi: 10.1378/chest.124.1.314.
PMID: 12853539BACKGROUNDKarsten J, Stueber T, Voigt N, Teschner E, Heinze H. Influence of different electrode belt positions on electrical impedance tomography imaging of regional ventilation: a prospective observational study. Crit Care. 2016 Jan 8;20:3. doi: 10.1186/s13054-015-1161-9.
PMID: 26743570BACKGROUNDLunardi AC, Paisani DM, Silva CCBMD, Cano DP, Tanaka C, Carvalho CRF. Comparison of lung expansion techniques on thoracoabdominal mechanics and incidence of pulmonary complications after upper abdominal surgery: a randomized and controlled trial. Chest. 2015 Oct;148(4):1003-1010. doi: 10.1378/chest.14-2696.
PMID: 25973670BACKGROUNDMeier T, Luepschen H, Karsten J, Leibecke T, Grossherr M, Gehring H, Leonhardt S. Assessment of regional lung recruitment and derecruitment during a PEEP trial based on electrical impedance tomography. Intensive Care Med. 2008 Mar;34(3):543-50. doi: 10.1007/s00134-007-0786-9. Epub 2007 Jul 25.
PMID: 17653529BACKGROUNDParke RL, Bloch A, McGuinness SP. Effect of Very-High-Flow Nasal Therapy on Airway Pressure and End-Expiratory Lung Impedance in Healthy Volunteers. Respir Care. 2015 Oct;60(10):1397-403. doi: 10.4187/respcare.04028. Epub 2015 Sep 1.
PMID: 26329355BACKGROUNDRiedel T, Richards T, Schibler A. The value of electrical impedance tomography in assessing the effect of body position and positive airway pressures on regional lung ventilation in spontaneously breathing subjects. Intensive Care Med. 2005 Nov;31(11):1522-8. doi: 10.1007/s00134-005-2734-x. Epub 2005 Sep 30.
PMID: 16195908BACKGROUNDStankiewicz-Rudnicki M, Gaszynski T, Gaszynski W. Assessment of regional ventilation in acute respiratory distress syndrome by electrical impedance tomography. Anaesthesiol Intensive Ther. 2015;47(1):77-81. doi: 10.5603/AIT.2015.0007.
PMID: 25751294BACKGROUNDWesterdahl E, Lindmark B, Eriksson T, Friberg O, Hedenstierna G, Tenling A. Deep-breathing exercises reduce atelectasis and improve pulmonary function after coronary artery bypass surgery. Chest. 2005 Nov;128(5):3482-8. doi: 10.1378/chest.128.5.3482.
PMID: 16304303BACKGROUNDRowley DD, Malinowski TP, Di Peppe JL, Sharkey RM, Gochenour DU, Enfield KB. A Randomized Controlled Trial Comparing Two Lung Expansion Therapies After Upper Abdominal Surgery. Respir Care. 2019 Oct;64(10):1181-1192. doi: 10.4187/respcare.06812. Epub 2019 May 21.
PMID: 31113857DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel D Rowley, MSc RRT-ACCS
Pulmonary Diagnostics & Respiratory Therapy Services, University of Virginia Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Masking Details
- Participant and Care Provider will be masked from electrical impedance tomography distribution of ventilation recording during lung expansion therapy to reduce risk of performance bias.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MSc RRT-ACCS
Study Record Dates
First Submitted
August 28, 2016
First Posted
September 8, 2016
Study Start
January 1, 2017
Primary Completion
November 12, 2018
Study Completion
November 12, 2018
Last Updated
November 19, 2018
Record last verified: 2018-11
Data Sharing
- IPD Sharing
- Will share
Intend to submit overall study findings to peer reviewed medical journal after study completion.